• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CORPORATION, ASHITAKA CAPIOX FX OXYGENATOR; OXYGENATOR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CORPORATION, ASHITAKA CAPIOX FX OXYGENATOR; OXYGENATOR, CARDIOPULMONARY BYPASS Back to Search Results
Catalog Number CX-XRX51920
Device Problem Coagulation in Device or Device Ingredient (1096)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 12/12/2017
Event Type  malfunction  
Manufacturer Narrative
Pma/510(k): k130520.The actual device was returned for evaluation.Visual inspection upon receipt found the formation of aggregated red thrombus inside the cardiotomy filter component.It did not find any visible break on it.The cardiotomy filter component was taken out of the reservoir.Visual inspection of the filter and the defoamer set inside the filter found aggregated red thrombus forming on the inner and outer surfaces of the filter and on the inner surface of the defoamer.The venous filter component was taken out of the reservoir.Visual inspection of the filter and the defoamer set inside the filter did not find any aggregated red thrombus like the one found in the cardiotomy filter component.Electron microscopic evaluation of the filter of the cardiotomy filter component revealed the adhesion of red blood cells, deformed red blood cells (echinocytes) and the formation of fibrin net.Electron microscopic evaluation of the defoamer of the cardiotomy filter component, focusing on the segment where red thrombus had formed revealed the adhesion of red blood cells, deformed red blood cells (echinocytes) and the formation of fibrin net.There was no presence of red thrombus on the outer surface.Electron microscopic evaluation of the filter of the venous filter component revealed the adhesion of red blood cells and the formation of fibrin net.Electron microscopic evaluation of the defoamer of the venous filter component revealed no adhesion of red blood cells.A review of the device history record and shipping inspection record of the involved product code/lot number combination revealed no findings.Ifu reference: adequate heparinization of the blood is required to prevent it from clotting.Do not reduce heparin during circulation.Otherwise, blood clotting might occur.There is no evidence that this event was related to a device defect or malfunction.The exact cause of the reported event cannot be definitively determined based on the available information.(b)(4).
 
Event Description
The user facility reported clots with the capiox device.Follow up communication with the user facility confirmed the following information: during the operation, clots occurred inside the venous reservoir.The actual sample was not changed out and the operation was completed with it.The procedure was completed successfully.The patient was no harmed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CAPIOX FX OXYGENATOR
Type of Device
OXYGENATOR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
TERUMO CORPORATION, ASHITAKA
150 maimaigi-cho
fujinomiya city, shizuoka 418
JA  418
Manufacturer (Section G)
TERUMO CORPORATION, ASHITAKA
reg. no. 9681834
150 maimaigi-cho
fujinomiya city, shizuoka 418
JA   418
Manufacturer Contact
terry callahan
reg. no. 2243441
2101 cottontail ln.
somerset, NJ 08873
8002837866
MDR Report Key7174796
MDR Text Key96727291
Report Number9681834-2017-00253
Device Sequence Number1
Product Code DTZ
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K071494
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other
Type of Report Initial
Report Date 01/09/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/09/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/31/2019
Device Catalogue NumberCX-XRX51920
Device Lot Number171027
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/14/2017
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Date Manufacturer Received12/12/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured10/27/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-